Invention Grant
US07829683B2 Polynucleotides encoding modified HIV-1 gp41 membrane polypeptides
有权
编码修饰的HIV-1 gp41膜多肽的多核苷酸
- Patent Title: Polynucleotides encoding modified HIV-1 gp41 membrane polypeptides
- Patent Title (中): 编码修饰的HIV-1 gp41膜多肽的多核苷酸
-
Application No.: US11826471Application Date: 2007-07-16
-
Publication No.: US07829683B2Publication Date: 2010-11-09
- Inventor: Pierre-Francois Serres
- Applicant: Pierre-Francois Serres
- Applicant Address: CH Nyon
- Assignee: Lomastar Technologies Sarl
- Current Assignee: Lomastar Technologies Sarl
- Current Assignee Address: CH Nyon
- Agency: Oliff & Berridge, PLC
- Priority: FR9714387 19971117
- Main IPC: A61K39/12
- IPC: A61K39/12

Abstract:
A method for obtaining a vaccine against the infection of an animal host by a retrovirus capable of penetrating into a host's target cell, where the target cell possesses a membrane receptor for a protein of the host, by preparing candidate vaccine agents based on a modified polypeptide having at least part of an envelope protein of the retrovirus, where the polypeptide has at least one fragment of an immunodominant region of the envelope protein, the fragment containing at least one conserved amino acid of the immunodominant region present in the pathogenic strain, wherein the polypeptide induces an immune response directed both against the immunodominant region and against the protein of the host; and selecting as a vaccine such a modified polypeptide chosen from those which induce an immune response directed against said immunodominant region of the envelope protein and not against the protein of the host.
Public/Granted literature
- US20080003229A1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral infection Public/Granted day:2008-01-03
Information query